http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2053767-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75341a17c769c0e707885908e998d4f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea0615907bfb2250f15c70de510f4c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47b45f8c687f02e1c027be986398923d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5c3a1057e648cc8a7222f1809744fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d3ac43eced193f563bf44373aeb7d07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2b1f56d0a85d503bf99c1bd7387a923
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1992-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d0109d9d31e9cec9bd78decd94705fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77bd5a4caf48a7a9794f07f891a0a767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87d66d5dc4b4535248a9e7b19ccf20ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88950ea01896e174c78ac23371ee824f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28523aaca1ad83e7f88ff7f3c40fee3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db774b6a35c42975f1e30c1dfc45ed5f
publicationDate 1996-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2053767-C1
titleOfInvention Complex therapeutic preparation for veterinary
abstract FIELD: veterinary. SUBSTANCE: preparation has components of nitrofuran order, immunostimulating agent and milk protein fraction base. Furacrilin is used from preparations of nitrofuran order and methyluracil is used as immunostimulating agent. Except for, complex has additionally novocain and ethacridine lactate at the following ratio of components, wt.-%: furacrilin 1.6-2; ethacridine lactate 1-1.5; methyluracil 1-2; novocain 0.5-1.0, and milk protein fraction - the rest. Preparation is used for treatment of young animals with gynecological disease in cows, gastro-intestinal diseases. EFFECT: enhanced quality of preparation, stability at storage (for 2 years), absence of by-side effects. 5 tbl
priorityDate 1992-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449288622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415767435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5452904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426073684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409298605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451216657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084

Total number of triples: 40.